Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002530160 | SCV000650769 | likely benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821578 | SCV002064939 | likely benign | not specified | 2017-08-09 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257827 | SCV002533149 | likely benign | Dyskeratosis congenita | 2021-11-08 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002257827 | SCV002609235 | likely benign | Dyskeratosis congenita | 2022-03-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004711172 | SCV005259058 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004538047 | SCV004746706 | likely benign | TERT-related disorder | 2019-09-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |